{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:41:18Z","timestamp":1761100878590},"reference-count":40,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1586\/14787210.4.5.743","type":"journal-article","created":{"date-parts":[[2006,12,4]],"date-time":"2006-12-04T09:21:35Z","timestamp":1165224095000},"page":"743-749","source":"Crossref","is-referenced-by-count":18,"title":["Telavancin: a new lipoglycopeptide with multiple mechanisms of action"],"prefix":"10.1586","volume":"4","author":[{"given":"Zeina A","family":"Kanafani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1093\/clinids\/3.Supplement_2.S200","volume":"3","author":"Griffith","year":"1981","journal-title":"Rev. Infect. Dis."},{"key":"CIT0002","first-page":"564","volume":"31","author":"Geraci","year":"1956","journal-title":"Mayo Clin. Proc."},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2004.04.006"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1128\/AAC.42.5.1303","volume":"42","author":"Kirst","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0924-8579(00)00303-4","volume":"16","author":"Moise","year":"2000","journal-title":"Int. J. Antimicrob. Agents"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.6.2398-2402.2004"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1128\/AAC.34.6.1227","volume":"34","author":"Small","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1086\/383027","volume":"38","author":"Woods","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.57.326"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.6.2149-2152.2004"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh156"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.8.3043-3050.2004"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.1.195-201.2005"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.3.862-867.2006"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1086\/429914"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2003.08.067"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.3.1127-1134.2005"},{"key":"CIT0018","unstructured":"Kaniga K, Blosser RS, Karlowsky JA, Sahm DF.In vitroactivity of telavancin (TD-6424) againstBacillus anthracis.44th Annual Interscience Conference on Antimicrobial Agents & Chemotherapy. Washington DC, USA. 30 October \u2013 2 November (2004) (Abstract E-2010)."},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.11.3602-3604.2003"},{"key":"CIT0020","unstructured":"Draghi DC, Jones ME, Thornsberry C, Flamm RK, Sahm DF. Telavancin activity against current and diverseStaphylococcus aureuspopulations.45th Annual Interscience Conference on Antimicrobial Agents & Chemotherapy. Washington DC, USA 16\u201319 December (2005)."},{"key":"CIT0021","unstructured":"Draghi DC, Jones ME, Flamm RK, Thornsberry C, Sahm DF. Telavancin activity against current and diverse populations of enterococci andStreptococcus pneumoniae. In:45th Annual Interscience Conference on Antimicrobial Agents & Chemotherapy. Washington DC, USA 16\u201319 December (2005)."},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl235"},{"key":"CIT0023","unstructured":"Finegold SM, Bolanos M, Summanen P, Molitoris DR.In vitroactivity of telavancin and six comparator agents against 460 anaerobic bacteria.45th Annual Interscience Conference on Antimicrobial Agents & Chemotherapy. Washington DC, USA 16\u201319 December (2005)."},{"key":"CIT0024","unstructured":"Eliopoulos GM, Wennersten CB, Sakoulas G, Moellering RC Jr.In vitrobactericidal activity of telavancin againstS. aureuswith relative tolerance to vancomycin.44th Annual International Conference on Antimicrobial Agents & Chemotherapy. Washington DC, USA 30 October \u2013 2 November (2004)."},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.8.3163-3165.2005"},{"key":"CIT0026","unstructured":"Krause K, Debabov D, Pace J, Kaniga K. Low frequency of spontaneous resistance to TD-6424 and delayed resistance selectionin vitroamong staphylococci and enterococci.43rd Annual Interscience Conference on Antimicrobial Agents & Chemotherapy. Chicago, IL, USA 14\u201317 September (2003)."},{"key":"CIT0027","unstructured":"Krause K, Benton BM, Higgins DL et al. Telavancin possesses low potential for resistant mutant selection in serial passage studies ofStaphylococcus aureusand enterococci.15th European Congress of Clinical Microbiology & Infectious Diseases. Copenhagen, Denmark, 2\u20135 April (2005)."},{"key":"CIT0028","unstructured":"Pace J, Judice K, Hegde SSet al. Activity of TD-6424 against methicillin-resistant and -susceptible Gram-positive bacteria.8th International Symposium on Staphylococci & Staphylococcal Infections. Regensburg, Germany (2002)."},{"key":"CIT0029","unstructured":"Debabov D, Pace J, Nodwell Met al. TD-6424, a novel rapidly bactericidal concentration-dependent antibiotic, acts through a unique dual mode of action.43rd Annual Interscience Conference on Antimicrobial Agents & Chemotherapy. Chicago, IL, USA 14\u201317 September (2003)."},{"key":"CIT0030","unstructured":"Barriere S, Shaw JP, Seroogy Jet al. Pharmacokinetic disposition and serum bactericidal activity following intravenous infusion of single and multiple ascending doses of TD-6424 in healthy male subjects.13th European Congress of Clinical Microbiology & Infectious Diseases. Glasgow, UK 10\u201313 May (2003)."},{"key":"CIT0031","unstructured":"Duchin K, Shaw JP, Spencer E et al. Single dose pharmacokinetics of telavancin in healthy elderly subjects.14th European Congress of Clinical Microbiology & Infectious Diseases. Prague, Czech Republic 1\u20134 May (2004)."},{"key":"CIT0032","unstructured":"Duchin K, Shaw JP, Seroogy J, Barriere S, Novack R. Effect of hemodialysis on single dose pharmacokinetics of telavancin.15th European Congress of Clinical Microbiology & Infectious Diseases. Copenhagen, Denmark 2\u20135 April (2005)."},{"key":"CIT0033","unstructured":"Duchin K, Shaw JP, Spencer E et al. Single dose pharmacokinetics of telavancin in subjects with renal dysfunction.14th European Congress of Clinical Microbiology & Infectious Diseases. Prague, Czech Republic 1\u20134 May (2004)."},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.2.788-790.2006"},{"key":"CIT0035","unstructured":"Gotfried M, Duchin K, Shaw JPet al. Telavancin penetrates well into human pulmonary epithelial lining fluid and alveolar macrophages and is unaffected by pulmonary surfactant.45th Annual Interscience Conference on Antimicrobial Agents & Chemotherapy. Washington DC, USA, 16\u201319 December (2005)."},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.2.770-773.2006"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.10.4344-4346.2005"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl222"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki198"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1177\/0091270004266620"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14787210.4.5.743","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T18:01:59Z","timestamp":1555956119000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14787210.4.5.743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,1,10]]},"published-print":{"date-parts":[[2006,10]]}},"alternative-id":["10.1586\/14787210.4.5.743"],"URL":"https:\/\/doi.org\/10.1586\/14787210.4.5.743","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}